tiprankstipranks
Trending News
More News >
Global Sweeteners Holdings Limited (HK:3889)
:3889

Global Sweeteners Holdings Limited (3889) AI Stock Analysis

Compare
0 Followers

Top Page

HK:3889

Global Sweeteners Holdings Limited

(3889)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 5.2)
Rating:41Neutral
Price Target:
HK$0.08
▼(-14.44% Downside)
The score is primarily constrained by very weak financial performance (negative operating margins, negative equity, and zero operating/free cash flow). Technicals also point to a weak trend with bearish momentum, while valuation signals are difficult to interpret due to a negative P/E and no dividend yield data.
Positive Factors
Business Model Strength
Global Sweeteners' role as a leading manufacturer supplying food makers and distributors supports durable demand. Serving diversified clients with bulk orders and established supply relationships underpins predictable revenue streams and reduces volatility in the medium term.
Stable Product Mix
Core sales of glucose, fructose and corn-derived products tie the business to staple ingredient demand across food, beverage and pharmaceutical sectors. These high-volume, low-discretion inputs create structural baseline demand and support steadier capacity utilization over months.
Recent Revenue Recovery
A 50.1% revenue increase year-over-year demonstrates the company can grow top-line via demand recovery or expanded shipments. This suggests operational scalability and commercial traction that, if sustained, can translate into improved utilization and long-term revenue resilience.
Negative Factors
Negative Equity / Leverage
Negative equity indicates liabilities exceed assets, creating structural solvency risk. This condition constrains access to debt and equity financing, raises refinancing and covenant pressures, and limits capital investment flexibility over the medium term.
Zero Operating and Free Cash Flow
Reported zero operating and free cash flow signals the company is not generating internal cash to fund operations or capex. Persistent lack of cash generation forces reliance on external financing, weakens liquidity buffers, and undermines ability to sustain investments.
Underlying Margin Weakness
Negative EBIT/EBITDA margins show core operations are loss-making and unable to cover operating costs. The reported net margin benefit from a one-off item masks structural unprofitability; absent sustainable margin recovery, earnings remain fragile and business economics are impaired.

Global Sweeteners Holdings Limited (3889) vs. iShares MSCI Hong Kong ETF (EWH)

Global Sweeteners Holdings Limited Business Overview & Revenue Model

Company DescriptionGlobal Sweeteners Holdings Limited (3889) is a leading manufacturer and supplier of sweeteners and food additives, primarily focused on the production of high-quality corn-based sweeteners, including glucose syrup and fructose syrup. The company operates in the food and beverage industry, catering to a diverse clientele that includes food manufacturers and distributors. With a commitment to innovation and sustainability, Global Sweeteners Holdings is dedicated to providing a range of products that meet the evolving needs of consumers and businesses worldwide.
How the Company Makes MoneyGlobal Sweeteners Holdings Limited generates revenue primarily through the production and sale of sweeteners and food additives. The company's core revenue streams include the sale of glucose syrup, fructose syrup, and other corn-derived products to various sectors such as food and beverage, pharmaceuticals, and consumer goods. By establishing strong relationships with food manufacturers and leveraging its production capabilities, the company is able to secure long-term contracts and bulk orders, providing a stable income source. Additionally, the company may benefit from strategic partnerships with major distributors and collaborations that enhance its market reach and operational efficiency, contributing to its overall earnings.

Global Sweeteners Holdings Limited Financial Statement Overview

Summary
Financial health appears very weak: profitability is strained by negative EBIT/EBITDA margins and net margin is influenced by a one-time item; the balance sheet shows negative equity (high financial risk); and both operating and free cash flow are zero, raising liquidity concerns.
Income Statement
40
Negative
The income statement shows a challenging financial situation. The Net Profit Margin is positive at about 10.7%, but this is misleading as it is skewed by a one-time item boosting net income, given prior negative results. Revenue growth is volatile but showed improvement from 2022 to 2023 with a 50.1% increase. However, EBIT and EBITDA margins are negative, indicating operational challenges. Overall, profitability is weak.
Balance Sheet
30
Negative
The balance sheet reflects financial instability. The Debt-to-Equity ratio is negative due to negative equity, highlighting high leverage and risk. The Equity Ratio is also negative, indicating more liabilities than assets. The company's financial structure is precarious, with significant liabilities overshadowing its assets.
Cash Flow
20
Very Negative
Cash flow analysis indicates severe weaknesses. Operating Cash Flow is zero in the latest year, a decline from positive cash flow in 2023. The Free Cash Flow is also zero, showing a lack of cash available after capital expenditures. This raises concerns about liquidity and the ability to sustain operations without external financing.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue544.63M623.46M440.81M359.57M728.10M769.02M
Gross Profit45.27M31.30M36.62M27.27M41.59M77.87M
EBITDA-94.09M120.27M-23.12M-31.48M48.22M201.39M
Net Income-162.28M66.62M289.52M-212.49M-96.26M-8.73M
Balance Sheet
Total Assets575.25M568.84M575.36M687.11M935.08M1.30B
Cash, Cash Equivalents and Short-Term Investments8.16M5.10M13.55M4.28M7.83M21.28M
Total Debt318.26M299.74M441.08M796.48M929.61M996.66M
Total Liabilities859.66M787.09M957.21M1.37B1.44B1.73B
Stockholders Equity-284.42M-218.25M-375.92M-675.04M-494.19M-418.63M
Cash Flow
Free Cash Flow-173.66M-192.38M87.80M13.14M-285.45M-30.01M
Operating Cash Flow-95.89M-114.66M88.39M13.28M-283.86M-20.20M
Investing Cash Flow-68.03M-76.51M-589.00K19.64M383.12M104.34M
Financing Cash Flow160.78M182.97M-78.30M-36.13M-112.93M-94.61M

Global Sweeteners Holdings Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.09
Price Trends
50DMA
0.09
Negative
100DMA
0.09
Negative
200DMA
0.10
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
43.00
Neutral
STOCH
48.72
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3889, the sentiment is Negative. The current price of 0.09 is above the 20-day moving average (MA) of 0.09, above the 50-day MA of 0.09, and below the 200-day MA of 0.10, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 43.00 is Neutral, neither overbought nor oversold. The STOCH value of 48.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:3889.

Global Sweeteners Holdings Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
HK$1.02B8.555.08%10.44%-1.19%-9.05%
71
Outperform
HK$310.00M11.745.48%0.78%5.43%-25.42%
68
Neutral
HK$2.30B10.3313.72%3.74%11.89%27.80%
63
Neutral
HK$1.09B2.4110.38%5.38%-6.58%16.23%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
44
Neutral
HK$1.12B0.7742.14%-81.25%
41
Neutral
HK$158.37M-0.96-6.04%-340.00%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:3889
Global Sweeteners Holdings Limited
0.08
-0.03
-28.07%
HK:1767
TS Wonders Holding Limited
0.31
0.12
63.16%
HK:1837
Natural Food International Holding Ltd.
1.05
0.57
118.75%
HK:2317
Vedan International (Holdings) Ltd.
0.67
0.24
55.81%
HK:3838
China Starch Holdings Limited
0.18
>-0.01
-0.54%
HK:0809
Global Bio-chem Technology Group Co. Ltd.
0.07
-0.02
-26.37%

Global Sweeteners Holdings Limited Corporate Events

Global Corn Group Tightens Nomination Committee Rules to Bolster Board Governance
Dec 18, 2025

Global Corn Group Limited has updated the terms of reference of its Board Nomination Committee, effective from 18 December 2025, building on its original 2012 framework and a prior amendment in 2013. The revised document formalises the committee’s composition requirements, specifying a minimum of three directors, a majority of whom must be independent non-executive directors and at least one of a different gender, and clarifies that the committee chair must be either the board chairman or an independent non-executive director, with the company secretary serving as committee secretary; these changes underscore the company’s efforts to enhance board diversity, independence and governance transparency in line with evolving regulatory and market expectations.

The most recent analyst rating on (HK:3889) stock is a Sell with a HK$0.09 price target. To see the full list of analyst forecasts on Global Sweeteners Holdings Limited stock, see the HK:3889 Stock Forecast page.

Global Corn Group CEO Resigns Amid Operational Restructuring
Nov 20, 2025

Global Corn Group Limited announced the resignation of its CEO, Mr. Wang Hui, effective November 20, 2025, as he plans to focus on other business ventures. The company has decided not to appoint a new CEO until operations at the Jinzhou Production Site resume or a clear business need arises, as the site remains suspended pending loan restructuring negotiations. The Shanghai Production Site continues to operate under its management team. The company’s joint chairmen, Mr. Wang Tieguang and Mr. Kong Zhanpeng, will oversee the restructuring and management of the production sites.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 28, 2026